SCOPUS 정보 검색 플랫폼

Volumn 356, Issue 26, 2007, Pages 2732-2733

Teratogenicity of SSRIs - Serious concern or much ado about little?

Author keywords

[No Author keywords available]

Indexed keywords

PAROXETINE; SEROTONIN UPTAKE INHIBITOR;

CARDIOVASCULAR MALFORMATION; CONGENITAL MALFORMATION; EDITORIAL; HEART VENTRICLE SEPTUM DEFECT; HUMAN; PRIORITY JOURNAL; TERATOGENICITY;

EID: 34347252336 PISSN: 00284793 EISSN: 15334406 Source Type: Journal
DOI: 10.1056/NEJMe078079 Document Type: Editorial

Times cited : (55)

References (8)

1
- 85030512094
- Use of paroxetine in first trimester of pregnancy may have a small increased risk of birth defects, compared to other antidepressants. Ottawa: Health Canada, October 2005. (Accessed June 7, 2007, at http://hcsc.gc.ca/ dhpmps/medeff/advisoriesavis/public/2005/paxil_3_paap_e.html.)
- Use of paroxetine in first trimester of pregnancy may have a small increased risk of birth defects, compared to other antidepressants. Ottawa: Health Canada, October 2005. (Accessed June 7, 2007, at http://hcsc.gc.ca/ dhpmps/medeff/advisoriesavis/public/2005/paxil_3_paap_e.html.)

2
- 85030510099
- FDA advising risk of birth defects with Paxil: agency requiring updated product labeling. Rockville, MD: Food and Drug Administration, December 8, 2005. (Accessed June 7, 2007, at http://www.fda.gov/bbs/topics/NEWS/2005/NEW01270. html.)
- FDA advising risk of birth defects with Paxil: agency requiring updated product labeling. Rockville, MD: Food and Drug Administration, December 8, 2005. (Accessed June 7, 2007, at http://www.fda.gov/bbs/topics/NEWS/2005/NEW01270. html.)

3
- 28244453710
- Paroxetine (Paxil) and congenital malformations
- Williams M, Wooltorton E. Paroxetine (Paxil) and congenital malformations. CMAJ 2005;173:1320-1.
- (2005) CMAJ , vol.173 , pp. 1320-1321
- Williams, M.¹ Wooltorton, E.²

4
- 34250842467
- Maternal use of selective serotonin reuptake inhibitors in early pregnancy and infant malformations. Birth Defects Res A Clin Mol
- Kallen BA, Otterblad Olausson P. Maternal use of selective serotonin reuptake inhibitors in early pregnancy and infant malformations. Birth Defects Res A Clin Mol Teratol 2007;79:301-8.
- (2007) Teratol , vol.79 , pp. 301-308
- Kallen, B.A.¹ Otterblad Olausson, P.²

5
- 33847215461
- First trimester exposure to paroxetine and risk of cardiac malformations in infants: The importance of dosage. Birth Defects Res B Dev
- Bérard A, Ramos E, Rey E, Blais L, St-Andre M, Oraichi D. First trimester exposure to paroxetine and risk of cardiac malformations in infants: the importance of dosage. Birth Defects Res B Dev Reprod Toxicol 2007;80:18-27.
- (2007) Reprod Toxicol , vol.80 , pp. 18-27
- Bérard, A.¹ Ramos, E.² Rey, E.³ Blais, L.⁴ St-Andre, M.⁵ Oraichi, D.⁶

6
- 33750484665
- Maternal use of selective serotonin reuptake inhibitors and risk of congenital malformations
- Wogelius P, Nørgaard M, Gislum M, et al. Maternal use of selective serotonin reuptake inhibitors and risk of congenital malformations. Epidemiology 2006;17:701-4.
- (2006) Epidemiology , vol.17 , pp. 701-704
- Wogelius, P.¹ Nørgaard, M.² Gislum, M.³

7
- 34347238272
- Use of selective serotoninreuptake inhibitors in pregnancy and the risk of birth defects
- Alwan S, Reefhuis J, Rasmussen SA, et al. Use of selective serotoninreuptake inhibitors in pregnancy and the risk of birth defects. N Engl J Med 2007;356:2684-92.
- (2007) N Engl J Med , vol.356 , pp. 2684-2692
- Alwan, S.¹ Reefhuis, J.² Rasmussen, S.A.³

8
- 34347255039
- Firsttrimester use of selective serotonin-reuptake inhibitors and the risk of birth defects
- Louik C, Lin AE, Werler MM, Hernández-Díaz S, Mitchell AA. Firsttrimester use of selective serotonin-reuptake inhibitors and the risk of birth defects. N Engl J Med 2007;356:2675-83
- (2007) N Engl J Med , vol.356 , pp. 2675-2683
- Louik, C.¹ Lin, A.E.² Werler, M.M.³ Hernández-Díaz, S.⁴ Mitchell, A.A.⁵

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.